Bristol-Myers Squibb

Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

www.bms.com.

Bristol-Myers Squibb RSS Channel

Filters
List of articles in category Bristol-Myers Squibb
Title Published Date
Bristol-Myers Squibb Foundation Launches $100 Million Initiative Targeting America's Type 2 Diabetes Crisis 11 November 2010
Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound 03 November 2010
Bristol-Myers Squibb Third Quarter Featured Solid Operating Performance 27 October 2010
Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc. 10 September 2010
Bristol-Myers Squibb to Acquire ZymoGenetics 08 September 2010
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation 26 August 2010
Ipilimumab Receives FDA Priority Review Designation 19 August 2010
Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS Growth 23 July 2010
ONGLYZA (saxagliptin) with Metformin as Initial Combination Therapy 28 June 2010
Bristol-Myers Squibb Signs Agreements with ICON and PAREXEL 15 June 2010
AVERROES Study Closes Early Due to Clear Evidence of Efficacy 11 June 2010
Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter 03 May 2010
Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus 10 March 2010
Bristol-Myers Squibb and Allergan Enter Global Agreement 05 March 2010
FDA Advisory Committee Recommends Approval of Belatacept 03 March 2010
Bristol-Myers Squibb supporting efforts to help survivors 21 January 2010
Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab 08 December 2009
"Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS 01 December 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement 11 November 2009
Bristol-Myers Squibb Achieves Strong Sales 23 October 2009

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs